Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Matthew Gall | Chief Financial Officer | 2023-10-12 | 5,000 | $8.37 | $41.85kBuy |
Boxer Capital LLC | Insider | 2023-08-23 | 219,638 | $16.87 | $3.71MSell |
Boxer Capital LLC | Insider | 2023-08-23 | 95,516 | $15.63 | $1.49MSell |
Boxer Capital LLC | Insider | 2023-08-23 | 34,846 | $14.19 | $494.46kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Mpm Bioventures 2018 LP | 15.83% | 5,674,086 | $59.98M | Insider |
Mpm Bioventures 2014 LP | 15.83% | 5,674,086 | $59.98M | Insider |
Ansbert Gadicke | 12.51% | 4,484,728 | $47.40M | Insider |
Ra Capital Management LP | 12.32% | 4,417,259 | $46.69M | Institution |
Blackrock Inc | 11.89% | 4,261,745 | $45.05M | Institution |
Mpm Asset Management LLC | 7.64% | 2,738,785 | $28.95M | Institution |
Aaron I. Davis | 6.21% | 2,226,301 | $23.53M | Insider |
Boxer Capital LLC | 5.03% | 1,804,058 | $19.07M | Insider |
Boxer Capital LLC | 5.03% | 1,804,058 | $19.07M | Institution |
Mpm Bioimpact LLC | 4.87% | 1,745,943 | $18.45M | Institution |